We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

92 hedge funds and large institutions have $848M invested in Heron Therapeutics in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 46 increasing their positions, 24 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

118% more call options, than puts

Call options by funds: $13.6M | Put options by funds: $6.25M

92% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 24

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

0% less capital invested

Capital invested by funds: $851M → $848M (-$2.79M)

7% less funds holding

Funds holding: 99 → 92 (-7)

46% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 13

Holders
92
Holders Change
-7
Holders Change %
-7.07%
% of All Funds
2.45%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
7
Increased
46
Reduced
24
Closed
13
Calls
$13.6M
Puts
$6.25M
Net Calls
+$7.36M
Net Calls Change
+$1.82M

Top Buyers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
+$19.6M
2
JHIU
Janus Henderson Investors US
Colorado
+$10.1M
3
KCM
Kingdon Capital Management
New York
+$9.33M
4
PHS
PFM Health Sciences
California
+$5.42M
5
TCM
Tekla Capital Management
Massachusetts
+$5.34M

Top Sellers

Rank Fund Capital Flow
1
Allianz Asset Management
Allianz Asset Management
Germany
-$5.03M
2
Invesco
Invesco
Georgia
-$4.62M
3
BC
Broadfin Capital
New York
-$4.2M
4
State Street
State Street
Massachusetts
-$4.18M
5
Goldman Sachs
Goldman Sachs
New York
-$2.86M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$3.72M +$1.3M +66,349 +48%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$2.67M +$89.4K +4,579 +3%
Deutsche Bank
28
Deutsche Bank
Germany
$2.59M +$1.52M +77,891 +118%
BIM
29
BlackRock Investment Management
Delaware
$2.22M +$363K +18,604 +18%
GH
30
GAM Holding
Switzerland
$2.13M +$1.15M +59,100 +100%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$2.07M -$1.08M -55,375 -33%
Charles Schwab
32
Charles Schwab
California
$2.02M +$171K +8,772 +9%
FAM
33
Fred Alger Management
New York
$1.81M -$1.39M -71,098 -42%
GC
34
Guggenheim Capital
Illinois
$1.78M -$122K -6,235 -6%
TI
35
Turner Investments
Pennsylvania
$1.74M – – –
TCIM
36
TIAA CREF Investment Management
New York
$1.74M +$141K +7,235 +8%
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$1.2M +$92.4K +4,732 +8%
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$1.2M -$41K -2,100 -3%
BGIM
39
Brandywine Global Investment Management
Pennsylvania
$1.07M -$285K -14,619 -20%
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$1.04M +$160K +8,180 +16%
CS
41
Credit Suisse
Switzerland
$1.01M +$19.2K +982 +2%
TA
42
Teachers Advisors
New York
$1.01M -$49.6K -2,539 -4%
Swiss National Bank
43
Swiss National Bank
Switzerland
$937K +$29.3K +1,500 +3%
PIM
44
Partner Investment Management
California
$871K -$15K -770 -2%
AllianceBernstein
45
AllianceBernstein
Tennessee
$856K – – –
Bank of America
46
Bank of America
North Carolina
$742K -$101K -5,165 -11%
Group One Trading
47
Group One Trading
Illinois
$682K +$446K +22,865 +153%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$635K +$118K +6,067 +21%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$632K +$109K +5,600 +19%
American Century Companies
50
American Century Companies
Missouri
$606K -$152K -7,811 -19%
1
2
3 4 5

HRTX Hedge Fund Activity: Q2 2016 in Review

92 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q2 2016, worth a combined $848M — down 0.33% from $851M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of HRTX and 7 opened new positions — a net loss of 6 holders — while 24 trimmed existing stakes and 46 added.

The largest buyer was Tang Capital Management, adding an estimated $19.6M. The largest seller was Allianz Asset Management, cutting an estimated $5.03M.

  • 92 institutional investors held Heron Therapeutics (HRTX) as of Q2 2016, down from 99 in Q1 2016.
  • Funds reported $848M of Heron Therapeutics stock for Q2 2016, down 0.33% quarter-over-quarter.
  • 7 funds opened new Heron Therapeutics positions in Q2 2016 and 13 closed out, a net change of -6 holders.
  • The largest Heron Therapeutics buyer in Q2 2016 was Tang Capital Management, an estimated $19.6M added.
  • The largest Heron Therapeutics seller in Q2 2016 was Allianz Asset Management, an estimated $5.03M sold.

Based on aggregated 13F filings for Q2 2016.